Results 171 to 180 of about 23,059 (205)
Some of the next articles are maybe not open access.
Mechanisms of integration in psychedelic-assisted therapy
Journal of Military, Veteran and Family Health, 2023LAY SUMMARY Psychedelic pharmacotherapies combined with structured psychotherapy have shown promise in the treatment of several psychological conditions. This type of therapy is known as psychedelic-assisted psychotherapy (PAP) and includes three phases: preparation, in-session support, and integration.
Nicole S. Coverdale, Douglas J. Cook
openaire +1 more source
Supportive Touch in Psychedelic Assisted Therapy
The American Journal of BioethicsIn August 2024, The U.S. Food and Drug Administration rejected Lykos Therapeutics, Inc.'s new drug application for midomafetamine with psychological intervention (MDMA-AT) to treat post-traumatic stress disorder (PTSD). Among the many issues raised during review was concern about a highly publicized case of alleged sexual misconduct by an unlicensed ...
Logan Neitzke-Spruill +3 more
openaire +2 more sources
Informed Consent in Psychedelic-Assisted Therapy
Humans have long used classical serotonergic psychedelics, such as psilocybin, for a variety of purposes. Entactogens, such as methylenedioxymethamphetamine (MDMA), emerged during the twentieth century and have likewise seen use in a broad range of settings.Mazdak M, Bradberry +2 more
openaire +2 more sources
Intentional Choices of Metaphors for Psychedelic-Assisted Therapy
Cognitive and Behavioral PracticeMitch Earleywine
exaly +2 more sources
Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults
2021Access to the Internet has upended long-standing myths and misconceptions about autism as autistic individuals are enabled through technology increasingly to influence the dialog around neurodiversity, the experience of being autistic, and the effectiveness of mental health interventions for autistic adults.
openaire +2 more sources
Epistemic Risk Reduction in Psychedelic-Assisted Therapy
Belief change is crucial to therapeutic benefit in psychedelic-assisted therapy as well as in more traditional forms of therapy. However, the use of psychedelics comes with a few unique challenges that require extra caution. First, drastic belief changes may occur faster than in regular therapy.Chiara, Caporuscio +1 more
openaire +2 more sources
Shrinking the know–do gap in psychedelic-assisted therapy
Nature Human BehaviourThere is a push to shrink the anticipated 17-year research-to-practice gap for psychedelic-assisted therapy (PAT), offering precarious hope to those with disabling mental health conditions. However, numerous questions regarding how PAT works, how well it works, for whom and in what context remain.
Ginger E. Nicol +3 more
openaire +2 more sources
Psychiatric Residents’ Perspectives on Psychedelics and Psychedelic Assisted Therapy
Journal of Psychoactive DrugsThis study evaluated the attitudes, knowledge, and educational experiences of psychiatry residents regarding psychedelics and psychedelic-assisted therapy (PAT). In 2023, we distributed an anonymous survey to United States psychiatry residents, assessing demographics, knowledge, and opinions on psychedelics/PAT.
Brian S. Barnett +6 more
openaire +2 more sources
Patient safety in psychedelic-assisted therapy
Australasian Psychiatry, 2023openaire +2 more sources
A Framework for Assessment of Adverse Events Occurring in Psychedelic Assisted Therapies
Journal of PsychopharmacologyObjective: Despite considerable research examining the efficacy of psychedelic-assisted therapies (PATs) for treating psychiatric disorders, assessment of adverse events (AEs) in PAT research has lagged. Current AE reporting standards in PAT trials are poorly calibrated to features of PAT that distinguish it from other treatments, leaving many ...
Roman Palitsky +12 more
openaire +3 more sources